Avery MA - Search Results

1

Identification of a new small molecule chemotype of Melanin Concentrating Hormone Receptor-1 antagonists using pharmacophore-based virtual screening.

Helal MA, Chittiboyina AG, Avery MA. Helal MA, et al. Among authors: avery ma. Bioorg Med Chem Lett. 2019 Dec 15;29(24):126741. doi: 10.1016/j.bmcl.2019.126741. Epub 2019 Oct 16. Bioorg Med Chem Lett. 2019. PMID: 31678007

2

Structure-activity relationships of the antimalarial agent artemisinin. 2. Effect of heteroatom substitution at O-11: synthesis and bioassay of N-alkyl-11-aza-9-desmethylartemisinins.

Avery MA, Bonk JD, Chong WK, Mehrotra S, Miller R, Milhous W, Goins DK, Venkatesan S, Wyandt C, Khan I, et al. Avery MA, et al. J Med Chem. 1995 Dec 22;38(26):5038-44. doi: 10.1021/jm00026a011. J Med Chem. 1995. PMID: 8544180

3

Structure-activity relationships of the antimalarial agent artemisinin. 3. Total synthesis of (+)-13-carbaartemisinin and related tetra- and tricyclic structures.

Avery MA, Fan P, Karle JM, Bonk JD, Miller R, Goins DK. Avery MA, et al. J Med Chem. 1996 Apr 26;39(9):1885-97. doi: 10.1021/jm950921y. J Med Chem. 1996. PMID: 8627612

4

Structure-activity relationships of the antimalarial agent artemisinin. 4. Effect of substitution at C-3.

Avery MA, Mehrotra S, Bonk JD, Vroman JA, Goins DK, Miller R. Avery MA, et al. J Med Chem. 1996 Jul 19;39(15):2900-6. doi: 10.1021/jm960200e. J Med Chem. 1996. PMID: 8709124

5

Structure-activity relationships of the antimalarial agent artemisinin. 5. Analogs of 10-deoxoartemisinin substituted at C-3 and C-9.

Avery MA, Mehrotra S, Johnson TL, Bonk JD, Vroman JA, Miller R. Avery MA, et al. J Med Chem. 1996 Oct 11;39(21):4149-55. doi: 10.1021/jm9603577. J Med Chem. 1996. PMID: 8863791

6

Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies.

Avery MA, Alvim-Gaston M, Rodrigues CR, Barreiro EJ, Cohen FE, Sabnis YA, Woolfrey JR. Avery MA, et al. J Med Chem. 2002 Jan 17;45(2):292-303. doi: 10.1021/jm0100234. J Med Chem. 2002. PMID: 11784134

7

Structure-activity relationships of the antimalarial agent artemisinin. 7. Direct modification of (+)-artemisinin and in vivo antimalarial screening of new, potential preclinical antimalarial candidates.

Avery MA, Alvim-Gaston M, Vroman JA, Wu B, Ager A, Peters W, Robinson BL, Charman W. Avery MA, et al. J Med Chem. 2002 Sep 12;45(19):4321-35. doi: 10.1021/jm020142z. J Med Chem. 2002. PMID: 12213073

8

Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria.

Avery MA, Muraleedharan KM, Desai PV, Bandyopadhyaya AK, Furtado MM, Tekwani BL. Avery MA, et al. J Med Chem. 2003 Sep 25;46(20):4244-58. doi: 10.1021/jm030181q. J Med Chem. 2003. PMID: 13678403

9

Diamine derivatives with antiparasitic activities.

Labadie GR, Choi SR, Avery MA. Labadie GR, et al. Among authors: avery ma. Bioorg Med Chem Lett. 2004 Feb 9;14(3):615-9. doi: 10.1016/j.bmcl.2003.11.055. Bioorg Med Chem Lett. 2004. PMID: 14741254

10

Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes.

Bhagavathula N, Nerusu KC, Lal A, Ellis CN, Chittiboyina A, Avery MA, Ho CI, Benson SC, Pershadsingh HA, Kurtz TW, Varani J. Bhagavathula N, et al. Among authors: avery ma. J Invest Dermatol. 2004 Jan;122(1):130-9. doi: 10.1046/j.0022-202X.2003.22111.x. J Invest Dermatol. 2004. PMID: 14962101 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters